Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 9,142

Document Document Title
WO/2018/189157A1
Methods are disclosed for converting a carboxylic acid by using a diboron reagent to convert the carboxylic acid or imide ester derivative of a carboxylic acid to a boronic ester. The method may involve providing an imide ester, such as ...  
WO/2018/190679A1
The present specification relates to: a nitrogen-containing compound; and a color-changing film, a backlight unit, and a display device, which comprise the same.  
WO/2018/188104A1
Disclosed is a method for preparing a borate ester on the basis of a tricyclopentadienyl rare earth metal complex, the method comprising the following steps: uniformly stirring and mixing a catalyst, a borane and a carbonyl compound for ...  
WO/2018/186670A1
A compound of chemical formula 1 and an organic light emitting element comprising the same are provided in the present specification.  
WO/2018/185266A1
The invention relates to compounds of formula: wherein R1 to R7 are as defined in the description. These compounds are useful as inhibitors of the YAP/TAZ-TEAD interaction.  
WO/2018/181800A1
The present invention addresses the problem of providing a kit and method capable of accurately measuring a measurement target substance in a biological sample across a broad concentration range extending from low to high concentrations....  
WO/2018/177861A1
The present invention relates to tris-aryl-amide derivatives having an anti-heparanase activity, in particular it relates toureido/thioureido/ether tris-aryl-amide derivatives of formula (I). The invention also relates to the use of such...  
WO/2018/181795A1
The present invention addresses the problem of providing a kit and method capable of accurately measuring a measurement target substance in a biological sample across a broad concentration range extending from low to high concentrations,...  
WO/2018/181797A1
The present invention addresses the problem of providing a kit and method capable of accurately measuring a measurement target substance in a biological sample across a measurement range extending from low to high concentrations. The pre...  
WO/2018/181798A1
The present invention addresses the problem of providing a kit, method and reagent capable of accurately measuring a measurement target substance across a broad concentration range extending from low to high concentrations, suppressing a...  
WO/2018/181799A1
The present invention addresses the problem of providing a kit, method and reagent capable of accurately measuring a measurement target substance across a broad concentration range extending from low to high concentrations, suppressing a...  
WO/2018/177857A1
The present invention relates to symmetrical 2-aminophenyl-benzazolyl-5-acetate compoundsof formula (I). Such compounds are endowed with an anti-heparanase activity. The present invention also relates to the use of such compounds as a me...  
WO/2018/183406A1
Composition, manufactures, and methods of making and using them, illustratively a process including the steps of: changing density of a composition including a neutron absorbent, the absorbent having a neutron absorption cross section gr...  
WO/2018/181796A1
The present invention addresses the problem of providing a kit and method capable of accurately measuring a measurement target substance in a biological sample across a measurement range extending from low to high concentrations. The pre...  
WO/2018/177860A1
The present invention relates to 2-(4-(4-(bromo-methoxybenzamido)benzylamino) phenyl)benzazole derivatives of formula (I) having an anti-heparanase activity. The invention also relates to the use of such compounds as a medicament, in par...  
WO/2018/171816A1
Disclosed in the present invention are a deuterated dipeptide boronic acid or an ester compound thereof, or a crystalline form, pharmaceutically acceptable hydrate or solvate thereof, the structure thereof being shown in formula (a), whe...  
WO/2018/172543A1
The invention relates to a trifunctionalised platform of formula (I), to the use thereof as a diagnostic or theragnostic agent and/or a medicament, and to a method for synthesis by the inverse electron demand Diels-Alder reaction from a ...  
WO/2018/173071A1
The present invention related to novel crystalline forms of Ixazomib citrate of formula-I and its process for preparation thereof. The chemical structure of said compound represented by the following formula-I. This invention also provid...  
WO/2018/169369A1
An electrolyte additive composition of the present invention comprises a novel borate-based lithium compound as well as a non-lithium additive. Therefore, when used for electrolyte, the present invention can enhance high-rate charging an...  
WO/2018/169112A1
Provided are a functional additive comprising a reduction-degradable additive, an oxidation-degradable additive, and a reactive additive and a method for preparing same, an electrolyte comprising the functional additive and a method for ...  
WO/2018/169368A1
An electrolyte additive composition of the present invention comprises a novel borate-based lithium compound as well as a nitrile-based compound. Therefore, when used for electrolyte, the present invention can enhance high-rate charging ...  
WO/2018/169370A1
An electrolyte additive composition of the present invention comprises a lithium-type additive while comprising a novel borate-based lithium compound, and thus the electrolyte additive composition, when used in an electrolyte, can improv...  
WO/2018/165325A1
Provided herein are methods for producing an organoboron product. The methods include combining a boron-containing reagent and a carbene precursor in the presence of a heme protein, e.g., a cytochrome c, a cytochrome P450, a globin, a pr...  
WO/2018/160845A1
This application describes compounds, compositions, and methods which are useful in treating, preventing, inhibiting, ameliorating, or eradicating the pathology and/or symptomology of a disease caused by a parasite.  
WO/2018/158582A1
Tri-component multi-functional boronated complexes (B-complexes), featuring reversible covalent bonds, are described, which incorporate a drug;a water-soluble moiety (e.g. polyethylene glycol (PEG) chains, cyclodextrins);and a targeting ...  
WO/2018/159628A1
An acylborane represented by general formula (1) and a method for producing the acylborane. (In the formula, each of R1 and R2 independently represents a hydrogen atom, a protecting group, a peptide residue, an alkyl group, an aryl group...  
WO/2018/157820A1
Disclosed in the present application are a compound represented by formula (I), or a pharmaceutically acceptable salt, a tautomer thereof, a stereoisomer thereof, or a geometrical isomer thereof, and uses thereof in the preparation of dr...  
WO/2018/159235A1
A composition which comprises a compound represented by formula (1) and at least one ingredient selected from the group consisting of curable compounds and resins. Provided are a film, an infrared cut filter, a solid imaging element, an ...  
WO/2018/159505A1
Provided are: a dissimilar-metal salt assembly which is a dendrimer capable of having a large number of, i.e., four or more types, particularly five or more types of dissimilar-metal salt compounds having dissimilar metals precisely inte...  
WO/2018/159834A1
Provided are a donor-acceptor type compound having a novel structure and an application of the donor-acceptor type compound. This enamine compound is represented by general formula (1) (in the formula: R1 represents an electron-accepting...  
WO/2018/158697A1
The present invention relates to a process for the preparation of compound of formula (I), wherein, R1 and R2 are each independently hydroxy, alkoxy, aryloxy, or aralkoxy; or R1 and R2 together form a moiety derived from an alpha-hydroxy...  
WO/2018/155484A1
Disclosed are: a phosphine oxide compound represented by formula (I), in which n represents an integer of 3 or higher, Ar1 represents an aromatic group of valence n, L represents a divalent linker group, and Ar2 and Ar3 each independentl...  
WO/2018/153471A1
Subject-matter of the invention is a hydrosilylatable mixture M comprising compound (C), which contains at least one carbocationic structure, and compound (A), which has at least one directly Si-bonded hydrogen atom, and compound (B), wh...  
WO/2018/155557A1
Disclosed is a rare earth complex which comprises a rare earth ion and a ligand that is coordinated to the rare earth ion and has a fused polycyclic aromatic group. The fused polycyclic aromatic group is a residue that is obtained by rem...  
WO/2018/155724A1
A compound represented by the following formula (1) is an excellent near-infrared emitter. R1 to R6 are H or a substituent and R7 is represented by the following formula (2). Ar11 is an aryl group, R11 is a substituent other than an aryl...  
WO/2018/149813A1
The present invention relates to a process for preparing substituted 2-nitrobiphenyls via Suzuki coupling using a palladium catalyst with specific phosphorus ligands and a solvent mixture containing water and an organic solvent which is ...  
WO/2018/150386A1
The present invention relates to an improved process for the preparation of a compound of formula (I), wherein PG1 may be independently selected from tert-butyloxycarbonyl (Boc), phthaloyl, 9-fluorenylmethyloxycarbonyl (Fmoc), triphenylm...  
WO/2018/150327A1
The present invention relates to methods for producing crisaborole, and methods for isolating and purifying crisaborole. The present invention also relates to intermediates, which may be used in the production of crisaborole, and methods...  
WO/2018/148721A1
The present invention includes methods and compositions that inhibit AKR1C3 enzymatic activity and consequently reduces androgen receptor (AR) transactivation, AR and prostate specific antigen (PSA) expression levels in, for example, pro...  
WO/2018/147204A1
Provided is a charge transporting varnish comprising: a charge transporting substance such as an aniline derivative and a thiophene derivative; an onium borate salt such as a compound represented by the formula; and an organic solvent.  
WO/2018/144607A1
A process for a continuous production of a boronic acid derivative and an apparatus of performing the process are disclosed.  
WO/2018/136401A1
Provided herein are compounds, such as a compound of Formula (I), as described herein, or a pharmaceutically acceptable salt thereof, that are immunoproteasome (such as LMP2 and LMP7) inhibitors. The compounds described herein can be use...  
WO/2018/133661A1
The present invention discloses a novel boric acid derivative and a pharmaceutical composition using the same, pertaining to the field of medicinal chemistry. The boric acid derivative is a compound represented by formula (I). The presen...  
WO/2018/134800A1
The object of the invention are dialkyl complexes of gallium and indium having general formula I: and their use for preparing polylactide-pharmaceutically active compound conjugates and for immortal ring-opening polymerisation of heteroc...  
WO/2018/131690A1
[Problem] To provide a novel agrochemical, especially a novel herbicide. [Solution] A ketone or oxime compound represented by formula (1), and a herbicide which contains this compound. (In the formula, B represents B-1 or B-2; Q represen...  
WO/2018/130988A1
The present invention provides cryptates derivatives of formula (I) and conjugates thereof with excellent fluorescent properties. The cryptates are useful in biological assays and methods for the detection and identification of various a...  
WO/2018/130542A1
The present invention relates to a complex comprising at least one dendrimer and at least one lanthanide, in which the dendrimer comprises a unit of formula (I), wherein: C1 is a group with a valency of 4 of formula >N-CH2-CH2-N<; and - ...  
WO/2018/130545A1
The present invention relates to a complex comprising at least one lanthanide (Ln) and at least one compound (C) comprising a unit of formula (I), said unit of formula (I) being covalently bound to at least one antenna that absorbs at a ...  
WO/2018/129328A1
Compositions and methods for optically-verified, sequence-controlled polymer synthesis are described.  
WO/2018/120126A1
Provided in the present invention are a light-emitting material and a preparation method therefor. The light-emitting material comprises an organic complex. The organic complex consists of tetrapyrrole macrocyclic ligand A, rare earth io...  

Matches 1 - 50 out of 9,142